{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:13:09Z","timestamp":1648512789815},"reference-count":30,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1157\/13100945","type":"journal-article","created":{"date-parts":[[2007,4,12]],"date-time":"2007-04-12T04:26:45Z","timestamp":1176352005000},"page":"508-514","source":"Crossref","is-referenced-by-count":3,"title":["Nuevos aspectos terap\u00e9uticos para el control de los factores de riesgo de la obesidad"],"prefix":"10.1016","volume":"128","author":[{"given":"Xavier","family":"Formiguera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Sierra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13100945_bib1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Toumilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1157\/13100945_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7326\/0003-4819-133-2-200007180-00008","article-title":"Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized controlled trial","volume":"133","author":"Ross","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1157\/13100945_bib3","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/oby.2001.69","article-title":"Is the relationship between adipose tissue and waist girth altered by weight loss in obese men?","volume":"9","author":"Par\u00e9","year":"2001","journal-title":"Obes Res"},{"key":"10.1157\/13100945_bib4","series-title":"WHO Technical Report Series, 894","year":"2000"},{"key":"10.1157\/13100945_bib5","unstructured":"National Institutes of Health. National Heart, Lung and Blood Institute and the North American Association for the Study of Obesity. The practical guide. Identification, evaluation and treatment of overweight and obesity in adults. NIH Publication number 00-4084. October, 2000."},{"key":"10.1157\/13100945_bib6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-142-7-200504050-00011","article-title":"Pharmacololgic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians","volume":"142","author":"Snow","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1157\/13100945_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0025-7753(00)71632-0","article-title":"Consenso SEEDO\u2019 2000 para la evaluaci\u00f3n del sobrepeso y la obesidad y el establecimiento de criterios de intervenci\u00f3n terap\u00e9utica","volume":"115","year":"2000","journal-title":"Med Clin (Barc)"},{"key":"10.1157\/13100945_bib8","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.ijo.0801059","article-title":"The effect of sibutramine on energy expenditure and apptetite during chronic treatment without dietary restriction","volume":"23","author":"Hansen","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"Suppl 4","key":"10.1157\/13100945_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sj.ijo.0801930","article-title":"When, for whom and how to use sibutramine?","volume":"25","author":"Astrup","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1157\/13100945_bib10","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","article-title":"Effect of sibutramine on weight maintenance after weight loss: a randomized trial. STORM Study Group. Sibutramine trial on obesity reduction and maintenance","volume":"356","author":"James","year":"2000","journal-title":"Lancet"},{"issue":"Suppl 4","key":"10.1157\/13100945_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/sj.ijo.0801934","article-title":"Sibutramine in overweight\/obese hypertensive patients","volume":"25","author":"Sharma","year":"2001","journal-title":"In J Obes Relat Metab Disord"},{"key":"10.1157\/13100945_bib12","article-title":"The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea","author":"Yee","year":"2006","journal-title":"Int J Obes"},{"key":"10.1157\/13100945_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","article-title":"Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients","volume":"352","author":"Sj\u00f6strom","year":"1998","journal-title":"Lancet"},{"key":"10.1157\/13100945_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/oby.2000.8","article-title":"Weight loss, weight maintenance and improved cardiovascular risk factors after two years of treatment with orlistat for obesity","volume":"8","author":"R\u00f6ssner","year":"2000","journal-title":"Obes Res"},{"key":"10.1157\/13100945_bib15","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.ijo.0801814","article-title":"The effects of orlistat on weight and serum lipids in obese patients with hypercolesterolemia: a randomized, double-blind, placebo-controlled, multicentre study","volume":"25","author":"Muls","year":"2001","journal-title":"In J Obes Relat Metab Disord"},{"key":"10.1157\/13100945_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.27.1.155","article-title":"Xenical in the prevention of diabetes in obese subjects (XENDOS) study","volume":"27","author":"Torgerson","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1157\/13100945_bib17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1463-1326.2005.00483.x","article-title":"XPERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance","volume":"7","author":"Toplak","year":"2005","journal-title":"Diabetes Obes Metab"},{"key":"10.1157\/13100945_bib18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/archfami.9.2.160","article-title":"Orlistat in the long-term treatment of obesity in primary care settings","volume":"9","author":"Hauptman","year":"2000","journal-title":"Arch Fam Med"},{"key":"10.1157\/13100945_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1467-789X.2003.00116.x","article-title":"Prevalence of overwight among children in Europe","volume":"4","author":"Lobstein","year":"2003","journal-title":"Obes Rev"},{"issue":"Suppl 1","key":"10.1157\/13100945_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000053308","article-title":"Type 2 diabetes in children: clinical aspects and risk factors","volume":"57","author":"Arslanian","year":"2002","journal-title":"Horm Res"},{"key":"10.1157\/13100945_bib21","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archpedi.157.8.821","article-title":"Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third NHANES, 1988-94","volume":"157","author":"Cook","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1157\/13100945_bib22","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1164\/rccm.2109080","article-title":"Epidemiololgy of obstructive sleep apnea: a population health perspective","volume":"165","author":"Young","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1157\/13100945_bib23","first-page":"30","article-title":"Sibutramine as an adjuvant therapy in adolescents suffering from morbid obesity","volume":"8","author":"Reisler","year":"2006","journal-title":"Isr Med Assoc J"},{"key":"10.1157\/13100945_bib24","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1001\/jama.293.23.2873","article-title":"Effect of orlistat on weight and body composition in obese adolescents","volume":"293","author":"Chanoine","year":"2005","journal-title":"JAMA"},{"key":"10.1157\/13100945_bib25","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(05)66348-9","article-title":"Fighting obesity and associated risk factors by antagonising cannabinoid type 1 receptors","volume":"365","author":"Pagotto","year":"2005","journal-title":"Lancet"},{"key":"10.1157\/13100945_bib26","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","article-title":"SR141716A, a potent and selective antagonist of the brain cannabinoid receptor","volume":"350","author":"Rinaldi-Carmona","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1157\/13100945_bib27","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35071088","article-title":"Leptinregulated endocannabinoids are involved in maintaining food intake","volume":"410","author":"Di Marzo","year":"2001","journal-title":"Nature"},{"key":"10.1157\/13100945_bib28","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia","volume":"353","author":"Despr\u00e9s","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1157\/13100945_bib29","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Van Gaal","year":"2005","journal-title":"Lancet"},{"key":"10.1157\/13100945_bib30","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients","volume":"295","author":"Pi-Sunyer","year":"2006","journal-title":"JAMA"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775307726374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775307726374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T04:25:52Z","timestamp":1546921552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775307726374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":30,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0025775307726374"],"URL":"https:\/\/doi.org\/10.1157\/13100945","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}